Celcuity Inc
Celcuity Inc (CELC) Option Chain
As of September 23, 2026, Celcuity Inc is trading at $77.69, a -2.88% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 59.0%. IV Rank is 12%.
Read more
Tracking the CELC option chain helps you see every strike and expiry on Celcuity Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Celcuity Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CELC options activity at a glance. Use our scanner to monitor the CELC option chain in real time and filter for the CELC options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CELC stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the CELC option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where CELC stock options are being actively traded and where they are not.
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer.
The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Celcuity Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen CELC options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of CELC stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile50.79% Neutral
- Market cap (M$)3,914
- 52 weeks high-47.03%
- 52 weeks low80.08%
- Analyst recommendationStrong Buy
1.00 - Target price$160.75
107.35% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-11
- P/E—
- Future P/E—
- EPS (ttm)-4.30
- EPS growth next 5 years—
As of September 23, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 19.78 | 2 | 0 | 3.96 | 7.69 | 9.70 | 13.60 | 70.00 | -12.49 | 1.00 | 1.30 | 0.00 | 1.15 | 0 | 930 | 80.22 |
| 35.16 | 14 | 0 | 4.76 | 2.69 | 5.80 | 9.10 | 75.00 | -6.24 | 1.60 | 2.90 | 0.00 | 2.25 | 0 | 216 | 64.84 |
| 52.30 | 27 | 0 | 4.70 | 0.00 | 3.20 | 6.20 | 80.00 | +0.01 | 3.50 | 5.20 | 2.31 | 2.04 | 6 | 678 | 47.70 |
| 68.07 | 412 | 1 | 3.30 | 0.00 | 2.40 | 4.20 | 85.00 | +6.26 | 5.80 | 8.70 | 7.31 | -0.06 | 0 | 71 | 31.93 |
| 80.45 | 231 | 27 | 0.90 | 0.00 | 0.05 | 1.75 | 90.00 | +12.51 | 9.60 | 12.10 | 12.31 | -1.46 | 0 | 10 | 19.55 |
As of September 23, 2026
Scan the full option chain in one place
Browse the full CELC option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→